🇺🇸 FDA
Pipeline program

TAK-755

TAK-755-2001

Phase 3 mab active

Quick answer

TAK-755 for Thrombotic Thrombocytopenic Purpura (TTP) is a Phase 3 program (mab) at TAKEDA PHARMACEUTICAL CO LTD with 3 ClinicalTrials.gov record(s).

Program details

Company
TAKEDA PHARMACEUTICAL CO LTD
Indication
Thrombotic Thrombocytopenic Purpura (TTP)
Phase
Phase 3
Modality
mab
Status
active

Clinical trials